# Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term

> **NCT03801252** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 186 (actual)

## Conditions studied

- Obesity
- Induction of Labor Affected Fetus / Newborn

## Interventions

- **DRUG:** Cefazolin
- **DRUG:** Placebo
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT03801252
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-12
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801252, "Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03801252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*